Z-WEHD-FMK: Irreversible Caspase-5 Inhibitor for Advanced Inflammation Research

Executive Summary: Z-WEHD-FMK (CAS 210345-00-9) is a peptide-based, irreversible inhibitor of inflammatory caspases, including caspase-1, -4, and -5, with proven utility in cell-permeable applications (APExBIO). It blocks caspase-mediated cleavage events, notably inhibiting golgin-84 cleavage and Chlamydia-induced Golgi fragmentation (Padia et al., 2025). Z-WEHD-FMK is used to investigate inflammation, apoptosis, and microbial pathogenesis, with benchmarked efficacy in cellular models. The compound is insoluble in water but soluble in DMSO and ethanol, with established storage and handling protocols. Its mechanistic specificity and reproducibility make it indispensable for cell biology and infectious disease research (see extended workflows).

Biological Rationale

Inflammatory caspases, particularly caspase-1, -4, and -5, play central roles in pyroptosis and innate immune signaling (Padia et al., 2025). Caspase-1 is activated by canonical inflammasomes, cleaving gasdermin D and pro-IL-1β, initiating pyroptosis and cytokine release. Caspase-4 and -5 (and murine caspase-11) mediate non-canonical pyroptosis by directly sensing cytosolic LPS and cleaving gasdermin D (Padia et al., 2025). Dysregulation of these pathways contributes to autoinflammatory diseases, tumorigenesis, and pathogen-mediated cellular remodeling. Z-WEHD-FMK is designed to selectively and irreversibly inhibit these caspases, thereby allowing precise dissection of their roles in cell death, inflammation, and microbial pathogenesis. Its utility extends to studying Chlamydia trachomatis infection, where blocking caspase-mediated cleavage events directly impedes bacterial proliferation and alters host lipid trafficking (see mechanistic insights).

Mechanism of Action of Z-WEHD-FMK

Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) is a synthetic tetrapeptide analog featuring a fluoromethyl ketone (FMK) reactive group. This FMK moiety covalently binds to the active site cysteine of target caspases, rendering them catalytically inactive (APExBIO). Z-WEHD-FMK irreversibly inhibits caspase-1, -4, and -5, with highest potency reported for caspase-5. By blocking caspase activity, it prevents the cleavage of key substrates such as golgin-84, which is essential for Golgi apparatus fragmentation during Chlamydia infection. This blockade disrupts downstream processes, including pyroptosis, cytokine maturation, and pathogen-driven cellular remodeling. Importantly, Z-WEHD-FMK is cell-permeable, allowing intracellular targeting in live cell assays. The compound’s irreversible inhibition ensures sustained caspase blockade during experimental time courses (for advanced mechanism).

Evidence & Benchmarks

• Z-WEHD-FMK irreversibly inhibits caspase-1, -4, and -5 in human cell models (Padia et al., 2025, DOI).
• In Chlamydia trachomatis-infected HeLa cells, 80 μM Z-WEHD-FMK for 9 hours blocks golgin-84 cleavage and prevents Golgi fragmentation (APExBIO).
• Z-WEHD-FMK reduces infectious Chlamydia inclusion counts by approximately 2 logs under benchmarked conditions (APExBIO).
• Pyroptosis induced by caspase-1 upregulation (e.g., by HOXC8 knockdown) is blocked in vitro by caspase-1 inhibitors, supporting the pathway targeted by Z-WEHD-FMK (Padia et al., 2025, DOI).
• Z-WEHD-FMK does not inhibit canonical apoptosis effectors (e.g., caspase-3/7) at standard concentrations (see specificity benchmarks).

Applications, Limits & Misconceptions

Z-WEHD-FMK is extensively used for:

• Blocking inflammatory cell death (pyroptosis) in immune and non-immune cell lines.
• Dissecting caspase-1/4/5-dependent signaling in apoptosis, cytokine maturation, and inflammasome activation.
• Modeling Chlamydia trachomatis pathogenesis by inhibiting host Golgi fragmentation and limiting bacterial replication (for translational models).

Compared to prior reviews, this article clarifies the specific experimental windows for Z-WEHD-FMK, focusing on validated concentrations and storage constraints, extending the troubleshooting guidance in this workflow piece.

Common Pitfalls or Misconceptions

• Non-specific inhibition: Z-WEHD-FMK does not block caspase-3/7 or other apoptosis-specific caspases at standard concentrations; it targets inflammatory caspases only.
• Solubility: The compound is insoluble in water; only dissolve in DMSO (≥46.33 mg/mL) or ethanol (≥26.32 mg/mL with ultrasonic aid).
• Storage: Store at -20°C; do not use solutions stored long-term as potency may decline.
• Pathway specificity: Inhibition is limited to caspase-dependent pathways; does not block ASC-independent cell death or non-caspase gasdermin activation.
• Cell permeability: Although cell-permeable, high cell density or poor mixing may reduce efficacy.

Workflow Integration & Parameters

For cell-based experiments, Z-WEHD-FMK is typically reconstituted in DMSO or ethanol. For Chlamydia infection models, use 80 μM for 9 hours in HeLa cells to block golgin-84 cleavage and inhibit bacterial proliferation. Ensure complete dissolution and avoid water as solvent. Store dry powder at -20°C. Prepare fresh solutions for each experiment. The molecular weight (MW) is 763.77, and the chemical formula is C37H42FN7O10. Researchers should document all conditions, including temperature and buffer, to ensure reproducibility. For detailed benchmarking and troubleshooting, see this workflow analysis (this article updates storage and solubility guidelines).

Conclusion & Outlook

Z-WEHD-FMK, supplied by APExBIO, is a validated, cell-permeable irreversible caspase-5 inhibitor, with key applications in inflammation and infectious disease research. Its use has clarified the roles of inflammatory caspases in pyroptosis, cytokine processing, and microbial pathogenesis. As research advances, Z-WEHD-FMK remains a gold-standard tool for dissecting complex caspase-dependent signaling in cellular models. For ordering and technical info, see the official Z-WEHD-FMK (A1924) product page.